RANI
Rani Therapeutics Holdings Inc - Ordinary Shares Class A

2,159
Mkt Cap
$137.32M
Volume
906,751.00
52W High
$3.87
52W Low
$0.387
PE Ratio
-1.43
RANI Fundamentals
Price
$1.13
Prev Close
$1.15
Open
$1.16
50D MA
$1.31
Beta
1.49
Avg. Volume
820,405.41
EPS (Annual)
-$1.05
P/B
-6.89
Rev/Employee
$9,790.48
$42.08
Loading...
Loading...
News
all
press releases
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Moderate Buy" from Brokerages
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five analysts that are presently covering the stock, MarketBeat...
MarketBeat·29d ago
News Placeholder
More News
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Trading 1.6% Higher - Time to Buy?
Rani Therapeutics (NASDAQ:RANI) Trading Up 1.6% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Brokerages
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has received an average rating of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat.com reports. One...
MarketBeat·3mo ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Stock Price Down 2.2% - What's Next?
Rani Therapeutics (NASDAQ:RANI) Trading Down 2.2% - Time to Sell...
MarketBeat·3mo ago
News Placeholder
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the stock...
MarketBeat·3mo ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3% - Here's Why
Rani Therapeutics (NASDAQ:RANI) Stock Price Up 1.3% - Here's Why...
MarketBeat·4mo ago
News Placeholder
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the stock...
MarketBeat·4mo ago
News Placeholder
Investors Purchase High Volume of Put Options on Rani Therapeutics (NASDAQ:RANI)
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock investors acquired 12,455 put options on the stock. This...
MarketBeat·4mo ago
News Placeholder
Rani Therapeutics (NASDAQ:RANI) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Rani Therapeutics (NASDAQ:RANI - Get Free Report) released its earnings results on Thursday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus...
MarketBeat·4mo ago
News Placeholder
Why Is Rani Therapeutics’ Stock Skyrocketing Pre-Market Today?
The total potential payments from the collaboration could reach $1.085 billion if all options are exercised.
Stocktwits·5mo ago
<
1
2
...
>

Latest RANI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.